Mark G. Malkin

5.1k total citations · 1 hit paper
71 papers, 3.2k citations indexed

About

Mark G. Malkin is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark G. Malkin has authored 71 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 31 papers in Pulmonary and Respiratory Medicine and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark G. Malkin's work include Glioma Diagnosis and Treatment (35 papers), Brain Metastases and Treatment (26 papers) and MRI in cancer diagnosis (9 papers). Mark G. Malkin is often cited by papers focused on Glioma Diagnosis and Treatment (35 papers), Brain Metastases and Treatment (26 papers) and MRI in cancer diagnosis (9 papers). Mark G. Malkin collaborates with scholars based in United States, Canada and Germany. Mark G. Malkin's co-authors include Ehud Arbit, Joseph H. Galicich, Kent E. Wallner, George Krol, Jennifer Connelly, Lauren E. Abrey, Kathleen M. Schmainda, Scott D. Rand, Jeffrey J. Raizer and Benjamin M. Ellingson and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer.

In The Last Decade

Mark G. Malkin

70 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma

1989 639 citations Kent E. Wallner, Joseph H. Galicich et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by Mark G. Malkin

Since Specialization

Citations

This map shows the geographic impact of Mark G. Malkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Malkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Malkin more than expected).

Fields of papers citing papers by Mark G. Malkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Malkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Malkin. The network helps show where Mark G. Malkin may publish in the future.

Co-authorship network of co-authors of Mark G. Malkin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark G. Malkin. A scholar is included among the top collaborators of Mark G. Malkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark G. Malkin. Mark G. Malkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disease-Based Prognostication: Neuro-Oncology 2023 ·Seminars in Neurology ·Kristin Waite, Gino Cioffi, Mark G. Malkin, Jill S. Barnholtz‐Sloan	1
2	tRNA Function and Dysregulation in Cancer 2022 ·Frontiers in Cell and Developmental Biology ·(unknown), Mark G. Malkin, Suyun Huang	22
3	Autologous Stem-Cell Transplantation for Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis 2018 ·Clinical Lymphoma Myeloma & Leukemia ·Iyad Alnahhas, (unknown), Mouaz Alsawas, Alicia Zukas, Larry J. Prokop, M. Hassan Murad, Mark G. Malkin	22
4	Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Review and Neuropsychological Case Study 2016 ·The Clinical Neuropsychologist ·Ashlee R. Loughan, (unknown), Robert Perna, Mark G. Malkin	13
5	Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma 2014 ·Neuro-Oncology ·Peter S. LaViolette, Nikolai J. Mickevicius, Elizabeth J. Cochran, Scott D. Rand, Jennifer Connelly, Joseph Bovi, Mark G. Malkin, Wade M. Mueller, Kathleen M. Schmainda	61
6	PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells 2014 ·Cancer Biology & Therapy ·Jane L. Roberts, Laurence Booth, Adam Conley, Nichola Cruickshanks, Mark G. Malkin, Rakesh C. Kukreja, Steven Grant, Andrew Poklepovic, Paul Dent	44
7	Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma 2013 ·Neuro-Oncology ·Peter S. LaViolette, (unknown), Melissa Prah, Scott D. Rand, Jennifer Connelly, Mark G. Malkin, Wade M. Mueller, Kathleen M. Schmainda	34
8	Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity 2010 ·Journal of Magnetic Resonance Imaging ·Benjamin M. Ellingson, Mark G. Malkin, Scott D. Rand, Jennifer Connelly, Carolyn Quinsey, Pete LaViolette, D. Bedekar, Kathleen M. Schmainda	214
9	Spatially quantifying microscopic tumor invasion and proliferation using a voxel‐wise solution to a glioma growth model and serial diffusion MRI 2010 ·Magnetic Resonance in Medicine ·Benjamin M. Ellingson, Peter S. LaViolette, Scott D. Rand, Mark G. Malkin, Jennifer Connelly, Wade M. Mueller, Robert W. Prost, Kathleen M. Schmainda	37
10	Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas 2010 ·Journal of Neuro-Oncology ·Benjamin M. Ellingson, Mark G. Malkin, Scott D. Rand, Pete LaViolette, Jennifer Connelly, Wade M. Mueller, Kathleen M. Schmainda	55
11	Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri 2009 ·Journal of Neuro-Oncology ·Benjamin M. Ellingson, Scott D. Rand, Mark G. Malkin, Kathleen M. Schmainda	13
12	Vinorelbine combined with a protracted course of temozolomide for recurrent brain Metastases: a phase I trial 2006 ·Journal of Neuro-Oncology ·Antonio Omuro, Jeffrey J. Raizer, Alexis Demopoulos, Mark G. Malkin, Lauren E. Abrey	42
13	Systemic high-dose intravenous methotrexate for central nervous system metastases 2005 ·Journal of Neuro-Oncology ·Andrew B. Lassman, Lauren E. Abrey, (unknown), Katherine S. Panageas, Martin Begemann, Mark G. Malkin, Jeffrey Raizer	104
14	The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma 2004 ·Cancer ·Rose Lai, Chau T. Dang, Mark G. Malkin, Lauren E. Abrey	121
15	Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatmentof malignant gliomas after radiation therapy 2004 ·Neuro-Oncology ·Jeffrey J. Raizer, Mark G. Malkin, (unknown), Lauren E. Abrey	23
16	Phase II Study of Antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in Patients With Recurrent Glioma 1999 ·Mayo Clinic Proceedings ·Jan C. Buckner, Mark G. Malkin, Eddie Reed, Terrence L. Cascino, Joel M. Reid, Matthew M. Ames, William P. Tong, (unknown), William D. Figg	23
17	“In Sickness and in Health” 1996 ·Journal of Psychosocial Oncology ·(unknown), Steven D. Passik, Mark G. Malkin	42
18	Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the brain tumor study group 1994 ·Journal of Neuro-Oncology ·Mark G. Malkin, Sylvan B. Green, David P. Byar, Thomas A. Strike, Peter C. Burger, F. Stephen Vogel, David Pistenmaa, M. S. Mahaley, Joseph Ransohoff, William R. Shapiro, John Mealey, James T. Robertson, Robert G. Selker, John C. Van Gilder	8
19	A versatile method for planning stereotactic brain implants 1993 ·Medical Physics ·Lowell L. Anderson, Patrick J. Harrington, (unknown), Ehud Arbit, Steven A. Leibel, Mark G. Malkin	10
20	Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma breakdown → 1989 ·International Journal of Radiation OncologyBiologyPhysics ·Kent E. Wallner, Joseph H. Galicich, George Krol, Ehud Arbit, Mark G. Malkin	639

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact